Advertisement

Index by author

April 01, 1992; Volume 41,Issue 4

A

  1. Albuquerque, E X

    1. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist.
      M Alkondon, E F Pereira, S Wonnacott and E X Albuquerque
      Molecular Pharmacology April 1992, 41 (4) 802-808;

  2. Alkondon, M

    1. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist.
      M Alkondon, E F Pereira, S Wonnacott and E X Albuquerque
      Molecular Pharmacology April 1992, 41 (4) 802-808;

  3. Amico, C

    1. Development profile of metabotropic glutamate receptor mRNA in rat brain.
      D F Condorelli, P Dell'Albani, C Amico, G Casabona, A A Genazzani, M A Sortino and F Nicoletti
      Molecular Pharmacology April 1992, 41 (4) 660-664;

  4. Appell, K C

    1. Antagonists that demonstrate species differences in neurokinin-1 receptors.
      K C Appell, B J Fragale, J Loscig, S Singh and B E Tomczuk
      Molecular Pharmacology April 1992, 41 (4) 772-778;

  5. Atkinson, B N

    1. Preferential desensitization of beta- versus alpha 2-adrenergic receptors accelerates loss of response to norepinephrine in primary glial cultures.
      B N Atkinson and K P Minneman
      Molecular Pharmacology April 1992, 41 (4) 688-694;

B

  1. Beaumont, A

    1. A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium.
      J M Soleilhac, E Lucas, A Beaumont, S Turcaud, J B Michel, D Ficheux, M C Fournié-Zaluski and B P Roques
      Molecular Pharmacology April 1992, 41 (4) 609-614;

  2. Begleiter, A

    1. Role of glutathione and glutathione S-transferase in chlorambucil resistance.
      W Z Yang, A Begleiter, J B Johnston, L G Israels and M R Mowat
      Molecular Pharmacology April 1992, 41 (4) 625-630;
    2. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia.
      A Begleiter, E Robotham and M K Leith
      Molecular Pharmacology April 1992, 41 (4) 677-682;

  3. Bleakman, D

    1. Calcium directly permeates kainate/alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid receptors in cultured cerebellar Purkinje neurons.
      J R Brorson, D Bleakman, P S Chard and R J Miller
      Molecular Pharmacology April 1992, 41 (4) 603-608;

  4. Boulay, G

    1. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa.
      G Boulay, G Servant, T T Luong, E Escher and G Guillemette
      Molecular Pharmacology April 1992, 41 (4) 809-815;

  5. Brorson, J R

    1. Calcium directly permeates kainate/alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid receptors in cultured cerebellar Purkinje neurons.
      J R Brorson, D Bleakman, P S Chard and R J Miller
      Molecular Pharmacology April 1992, 41 (4) 603-608;

  6. Brown, J A

    1. Molecular cloning and expression of the rhesus macaque D1 dopamine receptor gene.
      C A Machida, R P Searles, V Nipper, J A Brown, L B Kozell and K A Neve
      Molecular Pharmacology April 1992, 41 (4) 652-659;

  7. Burcham, P C

    1. Level of cytosolic free calcium during acetaminophen toxicity in mouse hepatocytes.
      A W Harman, S O Mahar, P C Burcham and B W Madsen
      Molecular Pharmacology April 1992, 41 (4) 665-670;

C

  1. Casabona, G

    1. Development profile of metabotropic glutamate receptor mRNA in rat brain.
      D F Condorelli, P Dell'Albani, C Amico, G Casabona, A A Genazzani, M A Sortino and F Nicoletti
      Molecular Pharmacology April 1992, 41 (4) 660-664;

  2. Chard, P S

    1. Calcium directly permeates kainate/alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid receptors in cultured cerebellar Purkinje neurons.
      J R Brorson, D Bleakman, P S Chard and R J Miller
      Molecular Pharmacology April 1992, 41 (4) 603-608;

  3. Charnet, P

    1. Structure of the gamma-less nicotinic acetylcholine receptor: learning from omission.
      P Charnet, C Labarca and H A Lester
      Molecular Pharmacology April 1992, 41 (4) 708-717;

  4. Comer, K A

    1. Immunological characterization of dehydroepiandrosterone sulfotransferase from human liver and adrenal.
      K A Comer and C N Falany
      Molecular Pharmacology April 1992, 41 (4) 645-651;

  5. Condorelli, D F

    1. Development profile of metabotropic glutamate receptor mRNA in rat brain.
      D F Condorelli, P Dell'Albani, C Amico, G Casabona, A A Genazzani, M A Sortino and F Nicoletti
      Molecular Pharmacology April 1992, 41 (4) 660-664;

  6. Cooper, D M

    1. Purinergic receptor regulation of signal transduction in NCB-20 cells.
      A Garritsen, Y Zhang and D M Cooper
      Molecular Pharmacology April 1992, 41 (4) 743-749;

  7. Costa, E

    1. Sodium nitroprusside inhibits N-methyl-D-aspartate-evoked calcium influx via a nitric oxide- and cGMP-independent mechanism.
      L Kiedrowski, E Costa and J T Wroblewski
      Molecular Pharmacology April 1992, 41 (4) 779-784;

  8. Cutting, G

    1. gamma-Aminobutyric acid A or C receptor? gamma-Aminobutyric acid rho 1 receptor RNA induces bicuculline-, barbiturate-, and benzodiazepine-insensitive gamma-aminobutyric acid responses in Xenopus oocytes.
      S Shimada, G Cutting and G R Uhl
      Molecular Pharmacology April 1992, 41 (4) 683-687;

D

  1. Dage, R C

    1. Functional interactions between two Ca2+ channel activators, (S)-Bay K 8644 and FPL 64176, in smooth muscle.
      D Rampe and R C Dage
      Molecular Pharmacology April 1992, 41 (4) 599-602;

  2. Daniels, A J

    1. Characterization of the neuropeptide Y-induced intracellular calcium release in human erythroleukemic cells.
      A J Daniels, J E Matthews, O Humberto Viveros and E R Lazarowski
      Molecular Pharmacology April 1992, 41 (4) 767-771;

  3. Dayton, J S

    1. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
      J S Dayton, L A Turka, C B Thompson and B S Mitchell
      Molecular Pharmacology April 1992, 41 (4) 671-676;

  4. Dell'Albani, P

    1. Development profile of metabotropic glutamate receptor mRNA in rat brain.
      D F Condorelli, P Dell'Albani, C Amico, G Casabona, A A Genazzani, M A Sortino and F Nicoletti
      Molecular Pharmacology April 1992, 41 (4) 660-664;

  5. DePriest, S

    1. Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site.
      C Romano, K Williams, S DePriest, R Seshadri, G R Marshall, M Israel and P B Molinoff
      Molecular Pharmacology April 1992, 41 (4) 785-792;

  6. Donevan, S D

    1. Arcaine blocks N-methyl-D-aspartate receptor responses by an open channel mechanism: whole-cell and single-channel recording studies in cultured hippocampal neurons.
      S D Donevan, S M Jones and M A Rogawski
      Molecular Pharmacology April 1992, 41 (4) 727-735;

  7. Dürr, U

    1. Ligand-operated synthesis of 4-series and 5-series leukotrienes in human neutrophils: critical dependence on exogenous free fatty acid supply.
      F Grimminger, U Dürr and W Seeger
      Molecular Pharmacology April 1992, 41 (4) 757-766;

E

  1. Ehlert, F J

    1. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
      E A Thomas, H H Hsu, M T Griffin, A L Hunter, T Luong and F J Ehlert
      Molecular Pharmacology April 1992, 41 (4) 718-726;

  2. Escher, E

    1. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa.
      G Boulay, G Servant, T T Luong, E Escher and G Guillemette
      Molecular Pharmacology April 1992, 41 (4) 809-815;

F

  1. Falany, C N

    1. Immunological characterization of dehydroepiandrosterone sulfotransferase from human liver and adrenal.
      K A Comer and C N Falany
      Molecular Pharmacology April 1992, 41 (4) 645-651;

  2. Ficheux, D

    1. A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium.
      J M Soleilhac, E Lucas, A Beaumont, S Turcaud, J B Michel, D Ficheux, M C Fournié-Zaluski and B P Roques
      Molecular Pharmacology April 1992, 41 (4) 609-614;

  3. Flynn, D D

    1. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors.
      D D Flynn, A A Vaishnav and D C Mash
      Molecular Pharmacology April 1992, 41 (4) 736-742;

  4. Förstermann, U

    1. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages.
      H H Schmidt, T D Warner, M Nakane, U Förstermann and F Murad
      Molecular Pharmacology April 1992, 41 (4) 615-624;

  5. Fournié-Zaluski, M C

    1. A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium.
      J M Soleilhac, E Lucas, A Beaumont, S Turcaud, J B Michel, D Ficheux, M C Fournié-Zaluski and B P Roques
      Molecular Pharmacology April 1992, 41 (4) 609-614;

  6. Fragale, B J

    1. Antagonists that demonstrate species differences in neurokinin-1 receptors.
      K C Appell, B J Fragale, J Loscig, S Singh and B E Tomczuk
      Molecular Pharmacology April 1992, 41 (4) 772-778;

G

  1. Garritsen, A

    1. Purinergic receptor regulation of signal transduction in NCB-20 cells.
      A Garritsen, Y Zhang and D M Cooper
      Molecular Pharmacology April 1992, 41 (4) 743-749;

  2. Genazzani, A A

    1. Development profile of metabotropic glutamate receptor mRNA in rat brain.
      D F Condorelli, P Dell'Albani, C Amico, G Casabona, A A Genazzani, M A Sortino and F Nicoletti
      Molecular Pharmacology April 1992, 41 (4) 660-664;

  3. Grace, K J

    1. Selective inhibition of cytokinesis in sea urchin embryos by the marine natural product pseudopterolide.
      K J Grace, M Medina, R S Jacobs and L Wilson
      Molecular Pharmacology April 1992, 41 (4) 631-638;

  4. Griffin, M T

    1. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
      E A Thomas, H H Hsu, M T Griffin, A L Hunter, T Luong and F J Ehlert
      Molecular Pharmacology April 1992, 41 (4) 718-726;

  5. Grimminger, F

    1. Ligand-operated synthesis of 4-series and 5-series leukotrienes in human neutrophils: critical dependence on exogenous free fatty acid supply.
      F Grimminger, U Dürr and W Seeger
      Molecular Pharmacology April 1992, 41 (4) 757-766;

  6. Guan, X M

    1. Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors.
      X M Guan, S J Peroutka and B K Kobilka
      Molecular Pharmacology April 1992, 41 (4) 695-698;

  7. Guillemette, G

    1. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa.
      G Boulay, G Servant, T T Luong, E Escher and G Guillemette
      Molecular Pharmacology April 1992, 41 (4) 809-815;

H

  1. Harman, A W

    1. Level of cytosolic free calcium during acetaminophen toxicity in mouse hepatocytes.
      A W Harman, S O Mahar, P C Burcham and B W Madsen
      Molecular Pharmacology April 1992, 41 (4) 665-670;

  2. Helm, S W

    1. L-proline activates glutamate and glycine receptors in cultured rat dorsal horn neurons.
      V Henzi, D B Reichling, S W Helm and A B MacDermott
      Molecular Pharmacology April 1992, 41 (4) 793-801;

  3. Henzi, V

    1. L-proline activates glutamate and glycine receptors in cultured rat dorsal horn neurons.
      V Henzi, D B Reichling, S W Helm and A B MacDermott
      Molecular Pharmacology April 1992, 41 (4) 793-801;

  4. Hsu, H H

    1. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
      E A Thomas, H H Hsu, M T Griffin, A L Hunter, T Luong and F J Ehlert
      Molecular Pharmacology April 1992, 41 (4) 718-726;

  5. Huber, B E

    1. Late-stage spermatids are characterized by expression of the "liver-specific" asialoglycoprotein receptor, RHL-1.
      B E Huber
      Molecular Pharmacology April 1992, 41 (4) 639-644;

  6. Humberto Viveros, O

    1. Characterization of the neuropeptide Y-induced intracellular calcium release in human erythroleukemic cells.
      A J Daniels, J E Matthews, O Humberto Viveros and E R Lazarowski
      Molecular Pharmacology April 1992, 41 (4) 767-771;

  7. Hunter, A L

    1. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
      E A Thomas, H H Hsu, M T Griffin, A L Hunter, T Luong and F J Ehlert
      Molecular Pharmacology April 1992, 41 (4) 718-726;

I

  1. Israel, M

    1. Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site.
      C Romano, K Williams, S DePriest, R Seshadri, G R Marshall, M Israel and P B Molinoff
      Molecular Pharmacology April 1992, 41 (4) 785-792;

  2. Israels, L G

    1. Role of glutathione and glutathione S-transferase in chlorambucil resistance.
      W Z Yang, A Begleiter, J B Johnston, L G Israels and M R Mowat
      Molecular Pharmacology April 1992, 41 (4) 625-630;

J

  1. Jacobs, R S

    1. Selective inhibition of cytokinesis in sea urchin embryos by the marine natural product pseudopterolide.
      K J Grace, M Medina, R S Jacobs and L Wilson
      Molecular Pharmacology April 1992, 41 (4) 631-638;

  2. Johnson, P S

    1. Characterization of organophosphate interactions at N-methyl-D-aspartate receptors in brain synaptic membranes.
      P S Johnson and E K Michaelis
      Molecular Pharmacology April 1992, 41 (4) 750-756;

  3. Johnston, J B

    1. Role of glutathione and glutathione S-transferase in chlorambucil resistance.
      W Z Yang, A Begleiter, J B Johnston, L G Israels and M R Mowat
      Molecular Pharmacology April 1992, 41 (4) 625-630;

  4. Jones, S M

    1. Arcaine blocks N-methyl-D-aspartate receptor responses by an open channel mechanism: whole-cell and single-channel recording studies in cultured hippocampal neurons.
      S D Donevan, S M Jones and M A Rogawski
      Molecular Pharmacology April 1992, 41 (4) 727-735;

K

  1. Kenakin, T P

    1. Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions.
      T P Kenakin
      Molecular Pharmacology April 1992, 41 (4) 699-707;

  2. Kiedrowski, L

    1. Sodium nitroprusside inhibits N-methyl-D-aspartate-evoked calcium influx via a nitric oxide- and cGMP-independent mechanism.
      L Kiedrowski, E Costa and J T Wroblewski
      Molecular Pharmacology April 1992, 41 (4) 779-784;

  3. Kobilka, B K

    1. Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors.
      X M Guan, S J Peroutka and B K Kobilka
      Molecular Pharmacology April 1992, 41 (4) 695-698;

  4. Kozell, L B

    1. Molecular cloning and expression of the rhesus macaque D1 dopamine receptor gene.
      C A Machida, R P Searles, V Nipper, J A Brown, L B Kozell and K A Neve
      Molecular Pharmacology April 1992, 41 (4) 652-659;

L

  1. Labarca, C

    1. Structure of the gamma-less nicotinic acetylcholine receptor: learning from omission.
      P Charnet, C Labarca and H A Lester
      Molecular Pharmacology April 1992, 41 (4) 708-717;

  2. Lazarowski, E R

    1. Characterization of the neuropeptide Y-induced intracellular calcium release in human erythroleukemic cells.
      A J Daniels, J E Matthews, O Humberto Viveros and E R Lazarowski
      Molecular Pharmacology April 1992, 41 (4) 767-771;

  3. Leith, M K

    1. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia.
      A Begleiter, E Robotham and M K Leith
      Molecular Pharmacology April 1992, 41 (4) 677-682;

  4. Lester, H A

    1. Structure of the gamma-less nicotinic acetylcholine receptor: learning from omission.
      P Charnet, C Labarca and H A Lester
      Molecular Pharmacology April 1992, 41 (4) 708-717;

  5. Loscig, J

    1. Antagonists that demonstrate species differences in neurokinin-1 receptors.
      K C Appell, B J Fragale, J Loscig, S Singh and B E Tomczuk
      Molecular Pharmacology April 1992, 41 (4) 772-778;

  6. Lucas, E

    1. A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium.
      J M Soleilhac, E Lucas, A Beaumont, S Turcaud, J B Michel, D Ficheux, M C Fournié-Zaluski and B P Roques
      Molecular Pharmacology April 1992, 41 (4) 609-614;

  7. Luong, T

    1. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
      E A Thomas, H H Hsu, M T Griffin, A L Hunter, T Luong and F J Ehlert
      Molecular Pharmacology April 1992, 41 (4) 718-726;

  8. Luong, T T

    1. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa.
      G Boulay, G Servant, T T Luong, E Escher and G Guillemette
      Molecular Pharmacology April 1992, 41 (4) 809-815;

M

  1. MacDermott, A B

    1. L-proline activates glutamate and glycine receptors in cultured rat dorsal horn neurons.
      V Henzi, D B Reichling, S W Helm and A B MacDermott
      Molecular Pharmacology April 1992, 41 (4) 793-801;

  2. Machida, C A

    1. Molecular cloning and expression of the rhesus macaque D1 dopamine receptor gene.
      C A Machida, R P Searles, V Nipper, J A Brown, L B Kozell and K A Neve
      Molecular Pharmacology April 1992, 41 (4) 652-659;

  3. Madsen, B W

    1. Level of cytosolic free calcium during acetaminophen toxicity in mouse hepatocytes.
      A W Harman, S O Mahar, P C Burcham and B W Madsen
      Molecular Pharmacology April 1992, 41 (4) 665-670;

  4. Mahar, S O

    1. Level of cytosolic free calcium during acetaminophen toxicity in mouse hepatocytes.
      A W Harman, S O Mahar, P C Burcham and B W Madsen
      Molecular Pharmacology April 1992, 41 (4) 665-670;

  5. Marshall, G R

    1. Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site.
      C Romano, K Williams, S DePriest, R Seshadri, G R Marshall, M Israel and P B Molinoff
      Molecular Pharmacology April 1992, 41 (4) 785-792;

  6. Mash, D C

    1. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors.
      D D Flynn, A A Vaishnav and D C Mash
      Molecular Pharmacology April 1992, 41 (4) 736-742;

  7. Matthews, J E

    1. Characterization of the neuropeptide Y-induced intracellular calcium release in human erythroleukemic cells.
      A J Daniels, J E Matthews, O Humberto Viveros and E R Lazarowski
      Molecular Pharmacology April 1992, 41 (4) 767-771;

  8. Medina, M

    1. Selective inhibition of cytokinesis in sea urchin embryos by the marine natural product pseudopterolide.
      K J Grace, M Medina, R S Jacobs and L Wilson
      Molecular Pharmacology April 1992, 41 (4) 631-638;

  9. Michaelis, E K

    1. Characterization of organophosphate interactions at N-methyl-D-aspartate receptors in brain synaptic membranes.
      P S Johnson and E K Michaelis
      Molecular Pharmacology April 1992, 41 (4) 750-756;

  10. Michel, J B

    1. A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium.
      J M Soleilhac, E Lucas, A Beaumont, S Turcaud, J B Michel, D Ficheux, M C Fournié-Zaluski and B P Roques
      Molecular Pharmacology April 1992, 41 (4) 609-614;

  11. Miller, R J

    1. Calcium directly permeates kainate/alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid receptors in cultured cerebellar Purkinje neurons.
      J R Brorson, D Bleakman, P S Chard and R J Miller
      Molecular Pharmacology April 1992, 41 (4) 603-608;

  12. Minneman, K P

    1. Preferential desensitization of beta- versus alpha 2-adrenergic receptors accelerates loss of response to norepinephrine in primary glial cultures.
      B N Atkinson and K P Minneman
      Molecular Pharmacology April 1992, 41 (4) 688-694;

  13. Mitchell, B S

    1. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
      J S Dayton, L A Turka, C B Thompson and B S Mitchell
      Molecular Pharmacology April 1992, 41 (4) 671-676;

  14. Molinoff, P B

    1. Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site.
      C Romano, K Williams, S DePriest, R Seshadri, G R Marshall, M Israel and P B Molinoff
      Molecular Pharmacology April 1992, 41 (4) 785-792;

  15. Mowat, M R

    1. Role of glutathione and glutathione S-transferase in chlorambucil resistance.
      W Z Yang, A Begleiter, J B Johnston, L G Israels and M R Mowat
      Molecular Pharmacology April 1992, 41 (4) 625-630;

  16. Murad, F

    1. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages.
      H H Schmidt, T D Warner, M Nakane, U Förstermann and F Murad
      Molecular Pharmacology April 1992, 41 (4) 615-624;

N

  1. Nakane, M

    1. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages.
      H H Schmidt, T D Warner, M Nakane, U Förstermann and F Murad
      Molecular Pharmacology April 1992, 41 (4) 615-624;

  2. Neve, K A

    1. Molecular cloning and expression of the rhesus macaque D1 dopamine receptor gene.
      C A Machida, R P Searles, V Nipper, J A Brown, L B Kozell and K A Neve
      Molecular Pharmacology April 1992, 41 (4) 652-659;

  3. Nicoletti, F

    1. Development profile of metabotropic glutamate receptor mRNA in rat brain.
      D F Condorelli, P Dell'Albani, C Amico, G Casabona, A A Genazzani, M A Sortino and F Nicoletti
      Molecular Pharmacology April 1992, 41 (4) 660-664;

  4. Nipper, V

    1. Molecular cloning and expression of the rhesus macaque D1 dopamine receptor gene.
      C A Machida, R P Searles, V Nipper, J A Brown, L B Kozell and K A Neve
      Molecular Pharmacology April 1992, 41 (4) 652-659;

P

  1. Pereira, E F

    1. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist.
      M Alkondon, E F Pereira, S Wonnacott and E X Albuquerque
      Molecular Pharmacology April 1992, 41 (4) 802-808;

  2. Peroutka, S J

    1. Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors.
      X M Guan, S J Peroutka and B K Kobilka
      Molecular Pharmacology April 1992, 41 (4) 695-698;

R

  1. Rampe, D

    1. Functional interactions between two Ca2+ channel activators, (S)-Bay K 8644 and FPL 64176, in smooth muscle.
      D Rampe and R C Dage
      Molecular Pharmacology April 1992, 41 (4) 599-602;

  2. Reichling, D B

    1. L-proline activates glutamate and glycine receptors in cultured rat dorsal horn neurons.
      V Henzi, D B Reichling, S W Helm and A B MacDermott
      Molecular Pharmacology April 1992, 41 (4) 793-801;

  3. Robotham, E

    1. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia.
      A Begleiter, E Robotham and M K Leith
      Molecular Pharmacology April 1992, 41 (4) 677-682;

  4. Rogawski, M A

    1. Arcaine blocks N-methyl-D-aspartate receptor responses by an open channel mechanism: whole-cell and single-channel recording studies in cultured hippocampal neurons.
      S D Donevan, S M Jones and M A Rogawski
      Molecular Pharmacology April 1992, 41 (4) 727-735;

  5. Romano, C

    1. Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site.
      C Romano, K Williams, S DePriest, R Seshadri, G R Marshall, M Israel and P B Molinoff
      Molecular Pharmacology April 1992, 41 (4) 785-792;

  6. Roques, B P

    1. A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium.
      J M Soleilhac, E Lucas, A Beaumont, S Turcaud, J B Michel, D Ficheux, M C Fournié-Zaluski and B P Roques
      Molecular Pharmacology April 1992, 41 (4) 609-614;

S

  1. Schmidt, H H

    1. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages.
      H H Schmidt, T D Warner, M Nakane, U Förstermann and F Murad
      Molecular Pharmacology April 1992, 41 (4) 615-624;

  2. Searles, R P

    1. Molecular cloning and expression of the rhesus macaque D1 dopamine receptor gene.
      C A Machida, R P Searles, V Nipper, J A Brown, L B Kozell and K A Neve
      Molecular Pharmacology April 1992, 41 (4) 652-659;

  3. Seeger, W

    1. Ligand-operated synthesis of 4-series and 5-series leukotrienes in human neutrophils: critical dependence on exogenous free fatty acid supply.
      F Grimminger, U Dürr and W Seeger
      Molecular Pharmacology April 1992, 41 (4) 757-766;

  4. Servant, G

    1. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa.
      G Boulay, G Servant, T T Luong, E Escher and G Guillemette
      Molecular Pharmacology April 1992, 41 (4) 809-815;

  5. Seshadri, R

    1. Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site.
      C Romano, K Williams, S DePriest, R Seshadri, G R Marshall, M Israel and P B Molinoff
      Molecular Pharmacology April 1992, 41 (4) 785-792;

  6. Shimada, S

    1. gamma-Aminobutyric acid A or C receptor? gamma-Aminobutyric acid rho 1 receptor RNA induces bicuculline-, barbiturate-, and benzodiazepine-insensitive gamma-aminobutyric acid responses in Xenopus oocytes.
      S Shimada, G Cutting and G R Uhl
      Molecular Pharmacology April 1992, 41 (4) 683-687;

  7. Singh, S

    1. Antagonists that demonstrate species differences in neurokinin-1 receptors.
      K C Appell, B J Fragale, J Loscig, S Singh and B E Tomczuk
      Molecular Pharmacology April 1992, 41 (4) 772-778;

  8. Soleilhac, J M

    1. A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium.
      J M Soleilhac, E Lucas, A Beaumont, S Turcaud, J B Michel, D Ficheux, M C Fournié-Zaluski and B P Roques
      Molecular Pharmacology April 1992, 41 (4) 609-614;

  9. Sortino, M A

    1. Development profile of metabotropic glutamate receptor mRNA in rat brain.
      D F Condorelli, P Dell'Albani, C Amico, G Casabona, A A Genazzani, M A Sortino and F Nicoletti
      Molecular Pharmacology April 1992, 41 (4) 660-664;

T

  1. Thomas, E A

    1. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
      E A Thomas, H H Hsu, M T Griffin, A L Hunter, T Luong and F J Ehlert
      Molecular Pharmacology April 1992, 41 (4) 718-726;

  2. Thompson, C B

    1. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
      J S Dayton, L A Turka, C B Thompson and B S Mitchell
      Molecular Pharmacology April 1992, 41 (4) 671-676;

  3. Tomczuk, B E

    1. Antagonists that demonstrate species differences in neurokinin-1 receptors.
      K C Appell, B J Fragale, J Loscig, S Singh and B E Tomczuk
      Molecular Pharmacology April 1992, 41 (4) 772-778;

  4. Turcaud, S

    1. A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium.
      J M Soleilhac, E Lucas, A Beaumont, S Turcaud, J B Michel, D Ficheux, M C Fournié-Zaluski and B P Roques
      Molecular Pharmacology April 1992, 41 (4) 609-614;

  5. Turka, L A

    1. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
      J S Dayton, L A Turka, C B Thompson and B S Mitchell
      Molecular Pharmacology April 1992, 41 (4) 671-676;

U

  1. Uhl, G R

    1. gamma-Aminobutyric acid A or C receptor? gamma-Aminobutyric acid rho 1 receptor RNA induces bicuculline-, barbiturate-, and benzodiazepine-insensitive gamma-aminobutyric acid responses in Xenopus oocytes.
      S Shimada, G Cutting and G R Uhl
      Molecular Pharmacology April 1992, 41 (4) 683-687;

V

  1. Vaishnav, A A

    1. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors.
      D D Flynn, A A Vaishnav and D C Mash
      Molecular Pharmacology April 1992, 41 (4) 736-742;

W

  1. Warner, T D

    1. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages.
      H H Schmidt, T D Warner, M Nakane, U Förstermann and F Murad
      Molecular Pharmacology April 1992, 41 (4) 615-624;

  2. Williams, K

    1. Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site.
      C Romano, K Williams, S DePriest, R Seshadri, G R Marshall, M Israel and P B Molinoff
      Molecular Pharmacology April 1992, 41 (4) 785-792;

  3. Wilson, L

    1. Selective inhibition of cytokinesis in sea urchin embryos by the marine natural product pseudopterolide.
      K J Grace, M Medina, R S Jacobs and L Wilson
      Molecular Pharmacology April 1992, 41 (4) 631-638;

  4. Wonnacott, S

    1. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist.
      M Alkondon, E F Pereira, S Wonnacott and E X Albuquerque
      Molecular Pharmacology April 1992, 41 (4) 802-808;

  5. Wroblewski, J T

    1. Sodium nitroprusside inhibits N-methyl-D-aspartate-evoked calcium influx via a nitric oxide- and cGMP-independent mechanism.
      L Kiedrowski, E Costa and J T Wroblewski
      Molecular Pharmacology April 1992, 41 (4) 779-784;

Y

  1. Yang, W Z

    1. Role of glutathione and glutathione S-transferase in chlorambucil resistance.
      W Z Yang, A Begleiter, J B Johnston, L G Israels and M R Mowat
      Molecular Pharmacology April 1992, 41 (4) 625-630;

Z

  1. Zhang, Y

    1. Purinergic receptor regulation of signal transduction in NCB-20 cells.
      A Garritsen, Y Zhang and D M Cooper
      Molecular Pharmacology April 1992, 41 (4) 743-749;
Back to top

In this issue